Distrust in health care during infectious disease outbreaks can have devastating consequences. Here’s what we can do about it.
Articles on Ebola 2026
Displaying all articles
There is no approved vaccine to curb the Ebola outbreak in the Democratic Republic of the Congo and Uganda. But new funding offers hope.
Ebola is a highly transmissible disease but its spread can be prevented through behavioural measures.
Borders are porous between North Kivu province of the DRC and neighbouring countries, so the potential for spread is highly likely.
Ebola is difficult to contain because of human social and behavioural factors. But it can be if 100% of the infected people’s contacts are identified and monitored.
Research has identified a range of health complications in Ebola survivors. These include eye complications and vision problems.
Instability in the DRC and Ebola’s deadly properties is making it hard to contain the virus.
The fast thinking Nigerian government used a tried and tested tracking system and pooled expertise to contain the ebola virus in three months.
Top contributors
-
Part-time lecturer at the Global Health & Social Medicine, Harvard University, and Lecturer at the School of Public Health, College of Health Sciences, University of Liberia
-
Associate professor, University of North Carolina at Chapel Hill
-
Professor of Ophthalmology, Emory University
-
Head of the Center for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases
-
Assistant Professor , Emory University
-
Lecturer in Virology, Queen's University Belfast
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Professor of Clinical Microbiology, University of Lagos
-
Professor, Infectious Diseases and Microbiology, The University of Queensland
-
Senior Research Fellow, Global and Tropical Health Division, Menzies School of Health Research
-
Senior Lecturer, School of Population Health, UNSW
-
Professor, School of Population Health, UNSW